Skip to main content

Scienture Holdings, Inc.

corporate_fare Company Profile

Scienture Holdings, Inc.

SCNX·NASDAQ·Life Sciences·CIK 0001382574

Scienture Holdings, Inc. is a pharmaceutical company that develops and sells products for central nervous system and cardiovascular diseases in the United States. The company is developing SCN-102, an oral liquid formulation of losartan potassium, which is currently in Phase 1 trials. SCN-102 is intended to treat hypertension, diabetic nephropathy, and reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy. Scienture Holdings also develops SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. Additionally, the company is working on SCN-106, a thrombolytic agent designed to bind to fibrin in clots and convert entrapped plasminogen to plasmin. Another product in development is SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional pain relief. Scienture Holdings, Inc. is headquartered in Commack, New York.

Scienture Holdings, Inc. (NASDAQ:SCNX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for SCNX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for SCNX spans 8-K, 10-Q.

Recent high-impact activity:

  • Scienture Q3 Revenue Hits $1.25M, Up 265% Sequentially on REZENOPY Launch
  • Scienture Q3 Revenue Jumps 113% to $1.25M as REZENOPY Launch Delivers $925K
  • Scienture Regains Nasdaq Bid-Price Compliance; Q3 Revenue Jumps 256% to ~$1.22M
  • Scienture's Q3 Revenue Hits $1.22M, Up 256% on REZENOPY Launch
  • Arbli™ Lands Formulary Wins at Three Top Pediatric Hospitals

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$431.61K
Net Income
-$41.51M
Diluted EPS
-$2.70
Op. Cash Flow
-$13.38M
Gross Profit
$331.48K
Operating Income
-$42.59M
Cash & Equivalents
$6.66M
Debt / Equity
0.00×
Net Margin
-96.18×
Shares Outstanding
40.63M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020707

Short Interest & Short Volume

3.14 days to cover

FINRA reported short interest of 117,350 shares in SCNX as of the October 30, 2026 settlement, a 10.9% increase from the prior period — about 3.1 days to cover at its recent average daily volume. On November 20, 2026, 37.5% of SCNX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)117,350 shares as of October 30, 2026
Change vs prior period▲ 10.9%
Days to cover3.14 at avg daily volume of 37,390
Daily short volume (FINRA facilities)37.5% of 23,232 shares on November 20, 2026
5-day average short volume53.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$2.46 +1.03% today
52-week range · as of 2026-11-19 $2.24 – $18.75
Market cap
$4.07M
Volume
29.9K (0.6× avg)
3-mo avg 46.5K
Live data · 2026-11-21 13:10 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SCNX - Latest Insights

SCNX
Nov 19, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.44
Real-time Price: $2.46 info
Change: +$0.025 (+1%) info
Market Cap: $4.073M info
SCNX
Nov 16, 2026, 8:30 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.01
Real-time Price: $2.46 info
Change: -$0.550 (-18%) info
Market Cap: $4.073M info
SCNX
Oct 19, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.92
Real-time Price: $2.46 info
Change: -$0.460 (-16%) info
Market Cap: $4.073M info
SCNX
Oct 13, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.03
Real-time Price: $2.46 info
Change: -$1.57 (-39%) info
Market Cap: $4.073M info
SCNX
Oct 02, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1864
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Sep 30, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.220
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Sep 22, 2026, 8:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3128
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Aug 14, 2026, 8:08 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.5298
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Aug 13, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.450
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Aug 12, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.440
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Jun 18, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.385
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Jun 09, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.3774
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
Jun 02, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3963
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 29, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.413
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 22, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.395
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 18, 2026, 8:38 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.4097
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 15, 2026, 4:38 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.403
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 15, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.3983
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 12, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.4175
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
SCNX
May 08, 2026, 4:36 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.400
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.073M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets